Is telehealth allowed to prescribe Wellbutrin in Florida?

Introduction

Navigating the world of telehealth regulations can be confusing, especially when seeking treatment for conditions like Binge Eating Disorder (BED). With rapidly changing telehealth laws and varying state regulations, patients often wonder: ‘Can I legally receive medication for BED through telehealth services?’ The good news is that for non-controlled medications commonly used for BED, such as Topamax (topiramate) and Wellbutrin (bupropion), telehealth remains a viable, legal option across the United States in 2026. This article clarifies the current telehealth prescribing landscape, helping you understand how and where you can access these treatments online.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding Telehealth Medication Rules for BED

Non-Controlled Status Means Easier Access

The most important fact to understand is that both Topamax and Wellbutrin are non-controlled medications, which means they fall under much more permissive telehealth prescribing rules than controlled substances like stimulants or anxiety medications.

While controlled substances face strict regulations under the Ryan Haight Act and various state laws, non-controlled medications like these are legally prescribable via telehealth in all 50 states when prescribed by a licensed provider who meets the standard of care requirements.

As the medical director at Klarity Health explains, ‘Non-controlled medications for BED have never been subject to the Ryan Haight Act restrictions. This means our providers can legally prescribe these treatments via video visits without requiring in-person examinations in most cases.’

State-Specific Requirements

While telehealth prescribing of non-controlled medications is universally permitted, some states have implemented periodic in-person requirements for ongoing care:

• States with NO in-person requirements: Most states including California, Delaware, Florida, Michigan, New York, South Carolina, Texas, and Wisconsin have no mandatory in-person visits for non-controlled medications prescribed via telehealth.

• States with periodic in-person requirements: A few states require an in-person visit within a certain timeframe for ongoing telehealth care. For example:

• Alabama: Requires an in-person visit if you have more than 4 telehealth visits in 12 months for the same condition

• Georgia: Requires an attempt to have an in-person exam at least annually for ongoing telehealth care

• New Hampshire: Requires an in-person exam at least every 12 months for ongoing medication management

Even in these states, the initial prescription can typically be obtained via telehealth, and the follow-up requirement can often be fulfilled by any collaborating provider, not necessarily the telehealth prescriber.

Who Can Prescribe BED Medications via Telehealth?

Provider Types and Practice Authority

Any licensed prescriber—MD, DO, NP, or PA—can prescribe non-controlled medications for BED via telehealth, though state laws determine their level of autonomy:

• Physicians (MDs/DOs) can prescribe these medications independently in all states.

• Nurse Practitioners (NPs) have full practice authority (independent prescribing) in 34 states plus DC, including California, New York, Michigan, and Wisconsin. In the remaining states (like Texas, Florida, and Georgia), NPs work under collaborative agreements with physicians but can still prescribe non-controlled medications.

• Physician Assistants (PAs) generally need some form of physician supervision or collaboration in most states, though the specific requirements vary.

At Klarity Health, our carefully vetted network includes providers licensed in multiple states who understand both the clinical aspects of BED and the telehealth regulations governing their practice.

What to Expect During a Telehealth BED Consultation

Evaluation Process

A legitimate telehealth evaluation for BED should include:

1. Identity verification – Confirming you’re in a state where the provider is licensed
2. Medical history review – Detailed questions about your health history, current medications, and any contraindications
3. Symptom assessment – Questions about your eating patterns, focusing on the clinical criteria for BED diagnosis
4. Discussion of treatment options – Including both medication and non-medication approaches

Be prepared to answer questions about your binge eating behaviors, including frequency (at least once weekly for 3 months is a key DSM-5 criterion), feelings of loss of control, and emotional distress associated with binges.

Documentation Requirements

Telehealth providers must maintain thorough documentation, including:

• Confirmation that you meet DSM-5 diagnostic criteria for BED
• Your informed consent for telehealth treatment
• Evidence that an appropriate evaluation was conducted
• A clear treatment plan that may include medication, therapy recommendations, or other interventions

Medication-Specific Considerations

Topamax (Topiramate) via Telehealth

Uses and effectiveness: Though primarily FDA-approved for seizures and migraines, Topamax is often prescribed off-label for BED due to its effects on impulse control and appetite regulation.

Telehealth considerations:

• Typically started at low doses and gradually increased
• Requires monitoring for cognitive side effects, weight changes, and metabolic parameters
• Not recommended during pregnancy due to birth defect risks (including cleft palate)
• May require regular follow-up appointments to assess effectiveness and manage side effects

Wellbutrin (Bupropion) via Telehealth

Uses and effectiveness: FDA-approved for depression and smoking cessation, Wellbutrin is sometimes used off-label for BED based on clinical evidence supporting its role in reducing binge frequency.

Telehealth considerations:

• Contraindicated in patients with a history of eating disorders with purging behaviors (anorexia, bulimia) due to seizure risk
• Carries a black box warning regarding suicidal thoughts, particularly in younger patients
• Requires monitoring for mood changes, blood pressure, and potential interactions
• May need more frequent initial follow-ups to ensure tolerability and effectiveness

Who Is Not a Good Candidate for Telehealth BED Treatment?

Certain circumstances may make you less suitable for telehealth BED treatment:

• History of anorexia or bulimia – Wellbutrin is specifically contraindicated
• Uncontrolled epilepsy or seizure disorders – Requires careful consideration with both medications
• Pregnancy or planning pregnancy – Topiramate poses significant risks to fetal development
• Severe medical instability – Urgent health issues may require in-person evaluation
• Need for controlled medications – If Vyvanse (the only FDA-approved medication for BED) is being considered, telehealth rules are more restrictive

Ensuring Safe and Legitimate Telehealth Care

Red Flags to Watch For

Avoid telehealth services that:

• Promise prescriptions before a proper evaluation
• Skip discussing non-medication approaches like therapy
• Conduct extremely brief consultations (under 5-10 minutes)
• Prescribe unusually high starting doses
• Directly sell medications instead of sending prescriptions to a pharmacy
• Don’t offer follow-up care or monitoring

At Klarity Health, we prioritize comprehensive care and follow evidence-based protocols that prioritize patient safety. Our providers conduct thorough evaluations, offer integrated care approaches, and maintain regular follow-up schedules to monitor progress and adjust treatment as needed.

Follow-up and Ongoing Care

For non-controlled BED medications, providers can often issue prescriptions with refills, reducing the frequency of required appointments. However, a typical follow-up schedule might include:

1. Initial evaluation
2. 2-week or 1-month check-in to assess medication tolerance
3. Monthly or bimonthly follow-ups initially
4. Less frequent visits once stable (though some states require periodic check-ins)

Prescription Monitoring Programs (PMPs) and BED Medications

While most states require prescribers to check the state PMP database before prescribing controlled substances, this requirement generally doesn’t apply to non-controlled medications like Topamax and Wellbutrin.

Your provider may still check the database as part of good clinical practice, particularly to verify you’re not taking other medications that might interact, but it’s not typically mandated by law for these specific medications.

Recent Regulatory Developments (2025-2026)

The telehealth landscape continues to evolve:

• In late 2025, the DEA extended pandemic-era flexibilities for controlled substances through December 2026
• Several states updated their NP scope of practice laws in 2023-2025, with Michigan and Wisconsin joining the ranks of ‘full practice’ states
• New Hampshire passed legislation in 2025 allowing telehealth prescribing of even Schedule II-IV medications (with annual in-person follow-up)
• New York implemented a rule requiring in-person visits for new controlle

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12